PM
Prosight Management Portfolio holdings
AUM
$484M
1-Year Est. Return
19.1%
This Fund
S&P 500
1 Year Est. Return
+19.1%
AUM
$484M
AUM Growth
+$67.4M
(+16%)
Holding
53
Top Buys
| 1 | +$43.2M | |
| 2 | +$35.9M | |
| 3 | +$31M | |
| 4 |
Veeva Systems
VEEV
|
+$23.9M |
| 5 |
Phreesia
PHR
|
+$20.2M |
Top Sells
| 1 | +$21.8M | |
| 2 | +$15.4M | |
| 3 | +$14M | |
| 4 |
DexCom
DXCM
|
+$13.1M |
| 5 |
Immunovant
IMVT
|
+$10.1M |
Sector Composition
| 1 | Healthcare | 99.58% |
| 2 | Industrials | 0.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Sight Sciences
SGHT
$273M
| – | – |
-439,941
|
|
||
52
Twist Bioscience
TWST
$2.88B
| – | – |
-75,000
|
|
||
53
Vertex Pharmaceuticals
VRTX
$126B
| – | – |
-20,500
|
|